Petri Bono

6PUBLICATIONS
31CO-AUTHORS
Biomolecular modelling and designTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Beyond the Catalogue: Design and Biological Enrichment as the Next Priorities in Higher-Risk MDS Drug Development.

|Nov 03, 2023
Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.

Jenna H Rannikko, Petri Bono, Johanna Hynninen

|Jan 12, 2022
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen

|Jan 11, 2022
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.

Stephane Oudard, Nadine Benhamouda, Bernard Escudier

|Jul 03, 2021
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients.

Oscar Brück, Moon Hee Lee, Riku Turkki

|Jun 03, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala

Pageof 1

Frequent Collaborators

2 joint publications

Jenna H Rannikko

2 joint publications

Maija Hollmén

1 joint publications

Reetta Virtakoivu

1 joint publications

Felix Vaura